Article Versions Notes

Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V. Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases. Pharmaceutics. 2022; 14(1):118. https://doi.org/10.3390/pharmaceutics14010118

Barrieu, Marion, Philip Chennell, Mouloud Yessaad, Yassine Bouattour, Mathieu Wasiak, Mireille Jouannet, Yoann Le Basle, and Valérie Sautou. 2022. "Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases" Pharmaceutics 14, no. 1: 118. https://doi.org/10.3390/pharmaceutics14010118

Barrieu, M., Chennell, P., Yessaad, M., Bouattour, Y., Wasiak, M., Jouannet, M., Le Basle, Y., & Sautou, V. (2022). Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases. Pharmaceutics, 14(1), 118. https://doi.org/10.3390/pharmaceutics14010118